PNOE to launch self-serve metabolic testing mask on October 1
PNOE will launch PNOE 2.0 on Oct. 1, a self-serve mask that measures oxygen and carbon dioxide for wellness guidance.
The new device, called PNOE 2.0, looks like a mask that covers the nose and mouth and straps around the back of the head. The Malden, Massachusetts-based company, which also has operations in Athens, Greece, says the main change from its current product is that users can administer the test themselves. Co-founder and CEO Apostolos Atsalakis said someone can walk into a gym, “just wear the mask, push the button, sit down,” and breathe for eight minutes. “That’s it. It’s that easy,” he said.
The self-service capability matters because PNOE’s current device requires a trained operator, which limits where it can be used. Atsalakis said a self-serve version could open the door to fitness centers without dedicated staff and potentially even pharmacies.
Metabolic testing is not new. It analyzes gases in a person’s breath to gauge how the body produces energy and has been around for more than a century. For decades, it has been the gold standard for measuring VO2 max, the maximum amount of oxygen the body can use during exercise and a widely used measure of cardiorespiratory fitness. But such tests have traditionally required bulky, expensive equipment found mainly in sports labs and hospitals, which is why they have largely been used by elite athletes and executive wellness programs.
PNOE, a 10-year-old company, promises the same accuracy in a portable package, paired with software that translates results into recommendations. “We made it accessible to everyone,” Atsalakis said. The company says its test captures 23 biomarkers, including VO2 max, resting metabolic rate—how many calories the body burns at rest—and metabolic flexibility, or how well the body switches between burning fat and carbohydrates. Atsalakis argues that these metrics answer questions blood tests cannot, such as how many calories a person needs or how they should train.
The timing favors PNOE. VO2 max has become a buzzword among longevity enthusiasts, in part because research has linked higher cardiorespiratory fitness to lower mortality. Atsalakis calls VO2 max the strongest predictor of human longevity and sees his company’s data as a kind of scorecard for the booming wellness industry.
The new device is smaller and more compact than its predecessor, with fewer parts. Atsalakis said that makes it more reliable. It was designed with Milan-based Design Group Italia over what he described as “a lot, a lot, a lot of iterations,” since a self-administered metabolic testing device had not been done before, according to TechCrunch.
The device also addresses a question post-pandemic users are likely to ask: who wore it last? The electronics detach from the silicone mask and straps, so multiple people can share the costly hardware while each user keeps their own mask.
PNOE is careful about what it claims. The device is not cleared by the U.S. Food and Drug Administration, and Atsalakis said “we do not provide medical recommendations.” PNOE considers itself a wellness device. “It’s like a body composition device, like a scale,” he said. “A doctor cannot prescribe medication based on our results.”
That could change down the road. Researchers have long explored whether compounds in human breath can signal diseases such as cancer, and Atsalakis believes the company’s growing trove of data could eventually help it flag health issues. But he acknowledged that full diagnoses are “definitely a couple of years away,” with regulatory hurdles likely stretching that timeline further. “We’re not there yet,” he said.
PNOE traces its roots to Atsalakis’s PhD work in sensing technologies at the University of Cambridge, when wearables were taking off and he became fascinated by what the breath could reveal about the body. He co-founded the company with Panos Papadiamantis, a childhood friend who is now the company’s chief product officer. The startup went through Y Combinator’s Winter 2019 batch, back when “longevity” was not yet the industry it is today. It has since raised about $22 million, including a recently closed $11 million round, from investors including 50 Years and Google Maps co-founder Lars Rasmussen, who is himself now based in Athens.
PNOE sells only to businesses, which then offer the test to their customers. Its clients include Equinox, where it is available at almost all clubs, Atsalakis said, as well as Four Seasons hotels, Red Bull and the NBA.